Transforming Growth Factor-Β in Psoriasis: Pathogenesis and Therapy
dc.contributor.author | Elder, James T. | en_US |
dc.contributor.author | Ellingsworth, Larry R. | en_US |
dc.contributor.author | Fisher, Gary J. | en_US |
dc.contributor.author | Voorhees, John J. | en_US |
dc.date.accessioned | 2010-06-01T21:23:21Z | |
dc.date.available | 2010-06-01T21:23:21Z | |
dc.date.issued | 1990-06 | en_US |
dc.identifier.citation | ELDER, JAMES T.; ELLINGSWORTH, LARRY R.; FISHER, GARY J.; VOORHEES, JOHN J. (1990). "Transforming Growth Factor-Β in Psoriasis: Pathogenesis and Therapy." Annals of the New York Academy of Sciences 593(1 Transforming Growth Factors: Chemistry, Biology, and Therapeutics ): 218-230. <http://hdl.handle.net/2027.42/74451> | en_US |
dc.identifier.issn | 0077-8923 | en_US |
dc.identifier.issn | 1749-6632 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/74451 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2165376&dopt=citation | en_US |
dc.format.extent | 1354742 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | 1990 The New York Academy of Sciences | en_US |
dc.title | Transforming Growth Factor-Β in Psoriasis: Pathogenesis and Therapy | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Science (General) | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Dermatology University of Michigan Ann Arbor, Michigan 48109 | en_US |
dc.contributor.affiliationother | Immunology Laboratory Connective Tissue Research Laboratories Collagen Corporation Palo Alto, California 94303 | en_US |
dc.identifier.pmid | 2165376 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/74451/1/j.1749-6632.1990.tb16114.x.pdf | |
dc.identifier.doi | 10.1111/j.1749-6632.1990.tb16114.x | en_US |
dc.identifier.source | Annals of the New York Academy of Sciences | en_US |
dc.identifier.citedreference | Krueger, G. G., P. R. Bergstresser, N. Lowe, J. J. Voorhees & G. D. Weinstein. 1984. Psoriasis. J. Amer. Acad. Dermatol. 11: 937 – 947. | en_US |
dc.identifier.citedreference | Weinstein, G. D. & E. J. Van Scott. 1965. Autoradiographic analysis of turnover times of normal and psoriatic epidermis. J. Invest. Dermatol. 45: 257. | en_US |
dc.identifier.citedreference | Bernard, B. A., D. Asselineau, L. Schaffar-Deshayes & M. Y. Darmon. 1988. Abnormal sequence of expression of differentiation markers in psoriatic epidermis: inversion of two steps in the differentiation program ? J. Invest. Dermatol. 90: 801 – 805. | en_US |
dc.identifier.citedreference | Braverman, I. M., & J. Sibley. 1982. Role of the microcirculation in the treatment and pathogenesis of psoriasis. J. Invest. Dermatol. 78: 12 – 17. | en_US |
dc.identifier.citedreference | Baker, B. S., A. F. Swain, H. Valdimarsson & L. Fry. 1984. T-cell subpopulations in the blood and skin of patients with psoriasis. Br. J. Dermatol. 110: 37 – 44. | en_US |
dc.identifier.citedreference | Hammar, H., S.-Q. Gu, A. Johannesson, K.-G. Sundkvist & P. Biberfeld. 1984. Subpopulations of mononuclear cells in microscopic lesions of psoriatic patients. Selective accumulation of suppressor/cytotoxic T cells in epidermis during the evolution of the lesion. J. Invest. Dermatol. 83: 416 – 420. | en_US |
dc.identifier.citedreference | Elder, J. T., G. J. Fisher, P. B. Lindquist, G. L. Bennett, M. R. Pittelkow, R. J. Coffey, L. Ellingsworth, R. Derynck & J. J. Voorhees. 1989. Overexpression of transforming growth factor Α in psoriatic epidermis. Science 243: 811 – 814. | en_US |
dc.identifier.citedreference | Grossman, R. M., J. Krueger, D. Yourish, A. Granelli-Piperno, D. P. Murphy, L. T. May, T. S. Kupper, P. B. Sehgal & A. B. Gottlieb. 1989. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc. Natl. Acad. Sci. USA 86: 6367 – 6371. | en_US |
dc.identifier.citedreference | Sporn, M. B., A. B. Roberts, L. M. Wakefield & R. K. Assoian. 1986. Transforming growth factor-Β: Biological function and chemical structure. Science 233: 532 – 534. | en_US |
dc.identifier.citedreference | Keski-Oja, J. & H. L. Moses. 1987. Growth inhibitory polypeptides in the regulation of cell proliferation. Med. Biol. 65: 13 – 20. | en_US |
dc.identifier.citedreference | Shipley, G. D., M. R. Pittelkow, J. J. Wille, R. E. Scott & H. L. Moses. 1986. Reversible inhibition of normal human prokeratinocyte proliferation by type Β transforming growth factor-growth inhibitor in serum-free medium. Cancer Res. 46: 2068 – 2071. | en_US |
dc.identifier.citedreference | Wilke, M. S., B. M. Hsu, J. J. Wille, M. R. Pittelkow & R. E. Scott. 1988. Biologic mechanisms for the regulation of normal human keratinocyte proliferation and differentiation. Am. J. Pathol. 131: 171 – 181. | en_US |
dc.identifier.citedreference | Ellingworth, L. R., J. E. Brennan, K. Fok, D. M. Rosen, H. Bentz, K. A. Piez & S. M. Seyedin. 1986. Antibodies to the N-terminal portion of cartilage-inducing factor A and transforming growth factor Β. J. Biol. Chem. 261: 12362 – 12367. | en_US |
dc.identifier.citedreference | Frolik, C., L. Wakefield, D. Smith & M. Sporn. 1984. Characterization of a membrane receptor for transforming growth factor-Β in normal rat kidney fibroblasts. J. Biol. Chem. 259: 10995 – 11000. | en_US |
dc.identifier.citedreference | Wille, J. J., M. R. Pittelkow, G. R. Shipley & R. E. Scott. 1984. Integrated Control of growth and differentiation of normal human prokeratinocytes cultured in serum-free medium: clonal analyses, growth kinetics, and cell cycle studies. J. Cell. Physiol. 121: 31 – 44. | en_US |
dc.identifier.citedreference | Boyce, S. T. & R. G. Ham. Normal human epidermal keratinocytes. In In Vitro Models for Cancer Research. Vol. III. M. M. Webber & L. I. Sekely, Eds.: 245 – 274. CRC Press. Boca Raton, FL. | en_US |
dc.identifier.citedreference | Nickoloff, B. J., R. S. Mitra, J. T. Elder, G. J. Fisher & J. J. Voorhees. 1989. Decreased growth inhibition by recombinant gamma interferon is associated with increased transforming growth factor-Α production in keratinocytes cultured from psoriatic lesions. Br. J. Dermatol. 121: 1 – 14. | en_US |
dc.identifier.citedreference | Elder, J. T., A. K. Gupta, G. J. Fisher & J. J. Voorhees. 1988. Cyclosporine inhibits ornithine decarboxylase gene expression and acute inflammation in response to phorbol ester treatment of hairless mouse skin. Transplant Proc. 20: 95 – 104. | en_US |
dc.identifier.citedreference | Derynck, R., J. A. Jarrett, E. Y. Chen, D. H. Eaton & J. R. Bell, R. K. Assoian, A. B. Roberts, M. B. Sporn & D. V. Goeddel. 1985. Human transforming growth factor-Β complementary DNA sequence and expression in normal and transformed cells. Nature 316: 701 – 705. | en_US |
dc.identifier.citedreference | Ginsburg, D., R. Zeheb, A. Y. Yang, U. M. Rafferty, P. A. Andreasen, L. Nielsen, K. Dano, R. V. Lebo & T. D. Gelehrter. cDNA cloning of human plasminogen activator-inhibitor from endothelial cells. J Clin Invest 78: 1673 – 1680. | en_US |
dc.identifier.citedreference | Ellingsworth, L. R., D. Nakayama, P. Segarini, J. Dasch, P. Carrillo & W. Waegell. Transforming growth factor-Βs are equipotent growth inhibitors of interleukin-1-induced thymocyte proliferation. Cell. Immun. 114: 41 – 54. | en_US |
dc.identifier.citedreference | Kimchi, A., X.-F. Wang, R. A. Weinberg, S. Cheifetz & J. MassaguÉ. 1988. Absence of TGF-Β receptors and growth inhibitory responses in retinoblastoma cells. Science 240: 196 – 199. | en_US |
dc.identifier.citedreference | Schwartz, P. M., L. C. Kugelman, Y. Coifman, L. M. Hough & L. M. Milstone. 1988. Human keratinocytes catabolize thymidine. J. Invest. Dermatol. 90: 8 – 12. | en_US |
dc.identifier.citedreference | Kane, C. J. M., P. C. Hanawalt, A. M. Knapp & J. N. Mansbridge. 1989. Immunohistochemical localization of transforming growth factor-Β protein in psoriasis. J. Invest. Dermatol. 92A: 455. | en_US |
dc.identifier.citedreference | Wakefield, L. M., D. M. Smith, K. C. Flanders & M. B. Sporn. 1988. Latent transforming growth factor-Β from human platelets. J. Biol. Chem. 263: 7646 – 7654. | en_US |
dc.identifier.citedreference | Massague, J. 1987. The TGF-Β family of growth and differentiation factors. Cell 49: 437 – 438. | en_US |
dc.identifier.citedreference | Derynck, R., P. B. Lindquist, A. Lee, D. Wen, J. Tamm, J. L. Graycar, L. Rhee, A. J. Mason, D. A. Miller, R. J. Coffey, H. L. Moses & E. Y. Chen. 1988. A new type of transforming growth factor-Β, TGF-Β. EMBO J. 7: 3737 – 3743. | en_US |
dc.identifier.citedreference | Jakowlew, S. B., P. J. Dillard, M. B. Sporn & A. B. Roberts. 1988. Complementary deoxyribonucleic acid cloning of a messenger ribonucleic acid encoding transforming growth factor Β4 from chicken embryo chondrocytes. Mol. Endo. 2: 1186 – 1195. | en_US |
dc.identifier.citedreference | Coffey, R. J., C. C. Bascom, N. J. Spies, R. Graves-Deal, B. E. Weissman & H. L. Moses. 1988. Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor Β. Mol. Cell Biol. 8: 3088 – 3093. | en_US |
dc.identifier.citedreference | Helseth, E., A. Dalen, G. Unsgaard, T. Skandsen, J. Grondahl-Hansen & L. R. Lund. 1988. Transforming growth factor-Β1 is a potent inducer of plasminogen activator inhibitor type-1 in human glioblastoma and carcinoma cell lines. Acta Pathol. Microbiol. Immunol. Scand. 96: 845 – 849. | en_US |
dc.identifier.citedreference | Keski-Oja, J., R. Raghow, M. Sawdey, D. J. Loskutoff, A. E. Postlethwaite, A. H. Kang & H. L. Moses. 1988. Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-Β. J. Biol. Chem. 263: 3111 – 3115. | en_US |
dc.identifier.citedreference | Wilke, M. S., B. M. Hsu & R. E. Scott. 1988. Two subtypes of reversible cell cycle restriction points exist in cultured normal human kertinocyte progenitor cells. Lab. Invest. 58: 660 – 666. | en_US |
dc.identifier.citedreference | Elder, J. T., A. Tavakkol, S. B. Klein, M. E. Zeigler, M. Wicha & J. J. Voorhees. 1990. Protooncogene expression in normal and psoriatic skin. J. Invest. Dermatol. 94: 19 – 25. | en_US |
dc.identifier.citedreference | Boyd, F. T. & J. Massague. 1989. Transforming growth factor-Β inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor. J. Biol. Chem. 264: 2272 – 2278. | en_US |
dc.identifier.citedreference | Mustoe, T. A., G. F. Pierce, A. Thomason, P. Gramaies, M. B. Sporn & T. F. Deuel. 1987. Accelerated healing of incisional wounds in rats induced by transforming growth factor-Β. Science 237: 1333 – 1336. | en_US |
dc.identifier.citedreference | Coffey, R. J., L. J. Kost, R. M. Lyons, H. L. Moses & N. F. LaRusso. 1987. Hepatic processing of transforming growth factor Β in the rat. J. Clin. Invest. 80: 750 – 757. | en_US |
dc.identifier.citedreference | Fisher, G. J., E. A. Duell, B. J. Nickoloff, T. M. Annesley, J. K. Kowalke, C. N. Ellis & J. J. Voorhees. 1988. Levels of cyclosporin in epidermis of treated psoriasis patients differentially inhibit growth of keratinocytes cultured in serum free versus serum containing media. J. Invest. Dermatol. 91: 142 – 146. | en_US |
dc.identifier.citedreference | Wahl, S. M., D. A. Hunt, H. L. Wong, S. Dougherty, N. McCartney-Francis, L. M. Wahl, L. Ellingsworth, J. A. Schmidt, G. Hall, A. B. Roberts & M. B. Sporn. Transforming growth factor-Β is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J. Immunol. 140: 3026 – 3032. | en_US |
dc.identifier.citedreference | Kehrl, J. H., L. M. Wakefield, A. B. Roberts, S. Jakowlew, M. Alvarez-Mon, R. Derynck, M. B. Sporn & A. S. Fauci. 1986. Production of transforming growth factor Β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163: 1037 – 1050. | en_US |
dc.identifier.citedreference | Nickoloff, B. J. & R. S. Mitra. 1988. Transforming growth factor-beta is a keratinocyte-derived lymphocyte inhibitory factor. J. Invest. Dermatol. 90A: 592. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.